People: Novartis AG (NOVN.VX)
Mr. Harry Kirsch has been appointed as Member of the Management Board, Chief Financial Officer of Novartis AG since May 1, 2013. Mr. Kirsch joined Novartis in 2003 and previously served as CFO of the Company’s Pharmaceuticals Division. At Novartis, he also served as CFO of Pharma Europe, and as Head of Business Planning & Analysis and Financial Operations for the Pharmaceuticals Division. Mr. Kirsch joined Novartis from Procter & Gamble (P&G) in the United States, where he was CFO of P&G's global pharmaceuticals business. Prior to that, he held finance positions in different categories of P&G's consumer goods business, technical operations, and Global Business Services organization. Mr. Kirsch studied industrial engineering and economics at the University of Karlsruhe in Germany (Diplom Wirtschaftsingenieur).
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|